The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

Ozempic made headlines after a study came out linking this and similar medications like Wegovy to an eye condition that can cause irreversible damage and permanent vision loss, including total ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut ...

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

In the first clinical trial of its kind, people taking semaglutide drank less alcohol, adding to its promise of fighting addiction.